Skip to content
PMND1: John Lieske, M.D. episode artwork

Aug 16, 2022 8 min

PMND1: John Lieske, M.D.

from Answers from the Lab Hosted by Mayo Clinic Laboratories

(00:31) Could you tell us a bit about yourself and your background? (01:11) Could you describe these new tests and when it would be appropriate to use each of them in the clinic? (03:16) Could you provide a little background on why MCL is making changes to the PLA2R test? (04:34) Could you describe the change to KDIGO guidelines and when it may be appropriate to skip the biopsy? How will these new tests help physicians implement these new guidelines in their practices?

Episode details come from the podcast's RSS feed.

Embed this episode

John Lieske, M.D., describes Mayo Clinic Laboratories' new test for primary membranous nephropathy. PMND1 is a diagnostic cascade that provides cost-effective testing to determine the antigen that's causing the kidney disease.

Ready to play

PMND1: John Lieske, M.D.

0:00 8:26

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Answers from the Lab?

This episode is 8 minutes long.

When was this Answers from the Lab episode published?

This episode was published on August 16, 2022.

Can I download this Answers from the Lab episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.